Northern Trust’s Rubius Therapeutics, Inc RUBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-71,366
| Closed | -$12.5K | – | 4663 |
|
|
2022
Q4 | $12.5K | Sell |
71,366
-127
| -0.2% | -$22 | ﹤0.01% | 4547 |
|
|
2022
Q3 | $31K | Hold |
71,493
| – | – | ﹤0.01% | 4457 |
|
|
2022
Q2 | $61K | Sell |
71,493
-341,032
| -83% | -$291K | ﹤0.01% | 4346 |
|
|
2022
Q1 | $2.27M | Sell |
412,525
-23,152
| -5% | -$128K | ﹤0.01% | 3037 |
|
|
2021
Q4 | $4.22M | Sell |
435,677
-12,782
| -3% | -$124K | ﹤0.01% | 2796 |
|
|
2021
Q3 | $8.02M | Sell |
448,459
-26,382
| -6% | -$472K | ﹤0.01% | 2443 |
|
|
2021
Q2 | $11.6M | Buy |
474,841
+77,428
| +19% | +$1.89M | ﹤0.01% | 2267 |
|
|
2021
Q1 | $10.5M | Sell |
397,413
-12,611
| -3% | -$334K | ﹤0.01% | 2252 |
|
|
2020
Q4 | $3.11M | Sell |
410,024
-10,848
| -3% | -$82.4K | ﹤0.01% | 2953 |
|
|
2020
Q3 | $2.11M | Sell |
420,872
-17,575
| -4% | -$88.1K | ﹤0.01% | 3038 |
|
|
2020
Q2 | $2.62M | Sell |
438,447
-14,866
| -3% | -$88.9K | ﹤0.01% | 2888 |
|
|
2020
Q1 | $2.02M | Buy |
453,313
+6,665
| +1% | +$29.7K | ﹤0.01% | 2852 |
|
|
2019
Q4 | $4.24M | Sell |
446,648
-785
| -0.2% | -$7.46K | ﹤0.01% | 2684 |
|
|
2019
Q3 | $3.51M | Buy |
447,433
+67,516
| +18% | +$530K | ﹤0.01% | 2759 |
|
|
2019
Q2 | $5.98M | Buy |
379,917
+12,753
| +3% | +$201K | ﹤0.01% | 2461 |
|
|
2019
Q1 | $6.65M | Buy |
367,164
+195,919
| +114% | +$3.55M | ﹤0.01% | 2381 |
|
|
2018
Q4 | $2.75M | Buy |
171,245
+36,674
| +27% | +$590K | ﹤0.01% | 2871 |
|
|
2018
Q3 | $3.23M | Buy |
+134,571
| New | +$3.23M | ﹤0.01% | 2948 |
|